Magnesium prevents phosphate-induced vascular calcification via TRPM7 and Pit-1 in an aortic tissue culture model

Hypertension Research

Volumn 40, Issue 6, 2017, Pages 562-567

  Sonou, Tomohiro ^a   Ohya, Masaki ^a   Yashiro, Mitsuru ^a   Masumoto, Asuka ^a   Nakashima, Yuri ^a   Ito, Teppei ^b   Mima, Toru ^a   Negi, Shigeo ^a   Kimura Suda, Hiromi ^b   Shigematsu, Takashi ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b CHITOSE INSTITUTE OF SCIENCE AND TECHNOLOGY   (Japan)

Author keywords

Magnesium; Pit 1; TRPM7; Vascular calcification

Indexed keywords

CALCIUM; MAGNESIUM; MINERAL; PHOSPHATE; PHOSPHORUS; TRANSCRIPTION FACTOR PIT 1; TRANSIENT RECEPTOR POTENTIAL CHANNEL M7; SLC20A1 PROTEIN, RAT; SODIUM PHOSPHATE COTRANSPORTER 3; TRANSIENT RECEPTOR POTENTIAL CHANNEL M; TRPM7 PROTEIN, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTIC TISSUE; ARTICLE; BLOOD VESSEL CALCIFICATION; CHEMILUMINESCENCE ANALYZER; CONTROLLED STUDY; ENERGY DISPERSIVE X RAY SPECTROSCOPY; FOURIER TRANSFORM INFRARED PHOTOACOUSTIC SPECTROSCOPY; IMAGING; NONHUMAN; PROTEIN EXPRESSION; RAT; SCANNING ELECTRON MICROSCOPY; SPECTROSCOPY; TISSUE CULTURE; VASCULAR RING; WESTERN BLOTTING; ANIMAL; AORTA; INFRARED SPECTROSCOPY; MALE; METABOLISM; SPECTROMETRY; SPRAGUE DAWLEY RAT; TISSUE CULTURE TECHNIQUE;

ANIMALS; AORTA; MAGNESIUM; MALE; MICROSCOPY, ELECTRON, SCANNING; PHOSPHATES; RATS, SPRAGUE-DAWLEY; SODIUM-PHOSPHATE COTRANSPORTER PROTEINS, TYPE III; SPECTROMETRY, X-RAY EMISSION; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TISSUE CULTURE TECHNIQUES; TRPM CATION CHANNELS; VASCULAR CALCIFICATION;

EID: 85020445086     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2016.188     Document Type: Article

References (27)

1. Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM. Arterial calcification, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 2001; 38: 938-942.
2. London GM, Guerin AP, Marchais SJ, Métivier F, Pannier B, Adda H. Arterial media calcification in end-stage renal disease. Nephrol Dial Transplant 2003; 18: 1731-1740.
3. Ohya M, Otani H, Kimura K, Saika Y, Fujii R, Yukawa S, Shigematsu T. Vascular calcification estimated by aortic calcification area index is significant predictive parameter of cardiovascular mortality in hemodialysis patients. Clin Exp Nephrol 2011; 15: 877-883.
4. László A, Reusz G, Nemcsik J. Ambulatory arterial stiffness in chronic kidney disease: a methodological review. Hypertens Res 2016; 39: 192-198.
5. Mune S, Shibata M, Hatamura I, Saji F, Okada T, Maeda Y, Sakaguchi T, Negi S, Shigematsu T. Mechanism of phosphate-induced calcification in rat aortic tissue culture: possible involvement of Pit-1 and apoptosis. Clin Exp Nephrol 2009; 13: 571-577.
6. Sonou T, Ohya M, Yashiro M, Masumoto A, Nakashima Y, Ito T, Mima T, Negi S, Kimura-Suda H, Shigematsu T. Mineral composition of phosphate-induced calcification in a rat aortic tissue culture model. J Atheroscler Thromb 2015; 22: 1197-1206.
7. Adamopoulos C, Pitt B, Sui X, Love TE, Zannad F, Ahmed A. Low serum magnesium and cardiovascular mortality in chronic heart failure: a propensity-matched study. Int J Cardiol 2009; 136: 270-277.
8. Ishimura E, Okuno S, Yamakawa T, Inaba M, Nishizawa Y. Serum magnesium concentration is a significant predictor of mortality in maintenance hemodialysis patients. Magnes Res 2007; 20: 237-244.
9. Sakaguchi Y, Fujii N, Shoji T, Hayashi T, Rakugi H, Isaka Y. Hypomagnesemia is a significant predictor of cardiovascular and non-cardiovascular mortality in patients undergoing hemodialysis. Kidney Int 2013; 85: 174-181.
10. Yamori Y, Sagara M, Mizushima S, Liu L, Ikeda K, Nara YCARDIAC Study Group. An inverse association between magnesium in 24-h urine and cardiovascular risk factors in middle-aged subjects in 50 CARDIAC Study populations. Hypertens Res 2015; 38: 219-225.
11. Salem S, Bruck H, Bahlmann FH, Peter M, Passlick-Deetjen J, Kretschmer A, Steppan S, Volsek M, Kribben A, Nierhaus M, Jankowski V, Zidek W, Jankowski J. Relationship between magnesium and clinical biomarkers on inhibition of vascular calcification. Am J Nephrol 2012; 35: 31-39.
12. Kanbay M, Yilmaz MI, Apetrii M, Saglam M, Yaman H, Unal HU, Gok M, Caglar K, Oguz Y, Yenicesu M, Cetinkaya H, Eyileten T, Acikel C, Vural A, Covic A. Relationship between serum magnesium levels and cardiovascular events in chronic kidney disease patients. Am J Nephrol 2012; 36: 228-237.
13. Ohya M, Negi S, Sakaguchi T, Koiwa F, Ando R, Komatsu Y, Shinoda T, Inaguma D, Joki N, Yamaka T, Ikeda M, Shigematsu T. Significance of serum magnesium as an independent correlative factor on the parathyroid hormone level in uremic patients. J Clin Endocrinol Metab 2014; 99: 3873-3878.
14. Gorgels TG, Waarsing JH, de Wolf A, ten Brink JB, Loves WJ, Bergen AA. Dietary magnesium, not calcium, prevents vascular calcification in a mouse model for pseudoxanthoma elasticum. J Mol Med 2010; 88: 467-475.
15. De Schutter TM, Behets GJ, Geryl H, Peter ME, Steppan S, Gundlach K, Passlick-Deetjen J, D'Haese PC, Neven E. Effect of a magnesium-based phosphate binder on medial calcification in a rat model of uremia. Kidney Int 2013; 83: 1109-1117.
16. Bai Y, Zhang J, Xu J, Cui L, Zhang H, Zhang S, Feng X. Magnesium prevents β-glycerophosphate-induced calcification in rat aortic vascular smooth muscle cells. Biomed Rep 2015; 3: 593-597.
17. Kircelli F, Peter ME, Sevinc Ok E, Celenk FG, Yilmaz M, Steppan S, Asci G, Ok E, Passlick-Deetjen J. Magnesium reduces calcification in bovine vascular smooth muscle cells in a dose-dependent manner. Nephrol Dial Transplant 2012; 27: 514-521.
18. Louvet L, Büchel J, Steppan S, Passlick-Deetjen J, Massy ZA. Magnesium prevents phosphate-induced calcification in human aortic vascular smooth muscle cells. Nephrol Dial Transplant 2013; 28: 869-878.
19. Meema HE, Oreopoulos DG, Rapaport A. Serum magnesium level and calcification in end-stage renal disease. Kidney Int 1987; 32: 388-394.
20. Tzanakis I, Pras A, Kounali D, Mamali V, Kartsonakis V, Mayopoulou-Symvoulidou D, Kallivretakis N. Mitral annular calcifications in haemodialysis patients: a possible protective role of magnesium. Nephrol Dial Transplant 1997; 12: 2036-2037.
21. Montezano AC, Zimmerman D, Yusuf H, Burger D, Chignalia AZ, Wadhera V, van Leeuwen FN, Touyz RM. Vascular smooth muscle cell differentiation to an osteogenic phenotype involves TRPM7 modulation by magnesium. Hypertension 2010; 56: 453-462.
22. Reynolds JL, Joannides AJ, Skepper JN, McNair R, Schurgers LJ, Proudfoot D, Jahnen-Dechent W, Weissberg PL, Shanahan CM. Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentration: a potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol 2004; 15: 2857-2867.
23. Mikroulis D, Mavrilas D, Kapolos J, Koutsoukos PG, Lolas C. Physicochemical and microscopical study of calcific deposits from natural and bioprosthetic heart valves. Comparison and implications for mineralization mechanism. J Mater Sci Mater Med 2002; 13: 885-889.
24. Becker A, Epple K, Muller KM, Schmitz I. A comparative study of clinically well-characterized human atherosclerotic plaques with histological, chemical, and ultrastructural methods. J Inorg Biochem 2004; 98: 2032-2038.
25. Lomashvili KA, Cobbs S, Hennigar RA, Hardcastle KI, O'Neill WC. Phosphate-induced vascular calcification: role of pyrophosphate and osteopontin. J Am Soc Nephrol 2004; 15: 1392-1401.
26. Lomashvili KA, Garg P, O'Neill WC. Chemical and hormonal determinants of vascular calcification. Kidney Int 2006; 69: 1464-1470.
27. Touyz RM. Magnesium in clinical medicine. Front Biosci 2004; 9: pp1278-1293.